Study results, soon to be published, show MesenCure treatment reduced study participants' hospitalization period by about half compared to a control group. All these patients had life-threatening pneumonia and respiratory distress caused by Covid-19.

The data shows that MesenCure treatment reduced mortality by about 70% compared with the control group. Only two of the first 30 severe Covid-19 patients treated with MesenCure died due to Covid-19 or its complications, while 14 of 60 similar patients in the control group died.

MesenCure treatment shortened the hospitalization period of severe Covid-19 patients by eight days on average, a reduction of 45% relative to the control group.

The experimental group included women and men aged 41.4 to 77.4. About 77% of the severe Covid-19 patients treated in three hospitals with MesenCure had one or more risk factors for poor prognosis: hypertension, hyperlipidemia, obesity and Type 2 diabetes. Most were treated during the fourth Covid-19 wave in Israel, dominated by the Delta strain.

The control group received the current standard of care — anti-inflammatory drugs in combination with steroids. This regimen, according to Bonus BioGroup, reduces mortality in hospitalized Covid-19 patients only slightly, from 25.8% to 21.8%, indicating that MesenCure is four times more effective.

"We are proud of our success in leading the world to be a safer place by developing a medication for severe Covid-19 patients, thereby dramatically reducing the threat to their lives," said Dr. Shai Meretzki, CEO of Bonus BioGroup.

"In less than two years from the epidemic outbreak, we are the first in the world to report an effective and significant treatment for severely ill patients."

According to a statement from Bonus BioGroup, an independent expert committee confirmed the findings of the Phase II clinical trial of MesenCure and recommended continuing toward Phase III. Meretzki told the Jerusalem Post that the company will apply for emergency use approval from European and US regulatory agencies. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Parents Beware: Ex-Psychic Calls Disney's Latest Animated Kids' Movie 'Really Disturbing'

Former DNI Tulsi Gabbard Shares Emotional Update on Husband Abraham's 'One-in-a-Million' Bone Cancer Battle (Video)

Sports Columnist Resigns When Seattle Times Spikes His Piece Supporting Female Athletes

AI Data Centers Are Becoming a Flash Point in the Midterm Election

Fentanyl Deaths Plunge 22% Thanks to Trump Admin Crackdown on Deadly Drug Crisis: Fox Exclusive

Christian Employers Win New Protections from EEOC Gender-Identity Mandates

Woman Arrested, Charged with Terror Plot Targeting NY State Capitol after Converting to Islam, Joining ISIS

Undercover, O'Keefe Exposes Alaska Voting Loophole as Senator Murkowski Opposes SAVE America Act

Supreme Court Allows Trump's White House Ballroom Construction to Continue for Now

Nike's 'Bud Light & Cracker Barrel' Moment: Iconic American Brand's Stock Plunges to 12-year Low after Canceling US Flag-Themed Shoe

The White House Needs a Ballroom. The Left Just Hates Who's Building It

Beijing Is Feeding Communist Propaganda to Kids in 100+ US Schools

Iowa Candidate Points to Farming Practices as Root Cause of Rising Cancer Rates

Minnesota: 23rd Defendant Sentenced to Prison in Feeding Our Future Fraud Scandal

Prosecutors Fight for Death Penalty in Charlie Kirk Case

Trump Declares 'Economic D-Day' against Iran's Islamic Regime

Attorney: Baby Boy at the Center of Surrogacy Case Has Had His First Heart Surgery

Faced With Legal Threat, Live Action Stands by the Word 'Killing' When Describing Abortion

Outrage Erupts in Spain as Socialists Move to Wipe Out Centuries-Old Christian Holiday

President Trump Honors Teen Lifeguard Who Saved Boy's Life